CU6 clarity pharmaceuticals ltd

CU6 - ASX Charts, page-2013

  1. 617 Posts.
    lightbulb Created with Sketch. 180

    I find the short sell trading dates of and around the 7th April more so than the positions themselves interesting. This ties in to remarks by JP Morgan Chase CEO Jamie Dimon on 9th April that his analysts have raised the risk of a U.S. inspired global recession this year to 60% only days after he and other U.S. bank CEOs met with the US Commerce Secretary to discuss the Trump administration's tariffs. He also stated that the current market volatile is potentially good for their capital markets business which deals in mergers and acquisitions. Not so good however for equity issuance like stock offerings, convertibles and private placements. From these remarks alone I am of the belief at present that this is probably what we are seeing in JP Morgan’s short side positioning not only in CU6 but many other stocks locally and globally as they seek to insulate both themselves and or their client base from this assessed rise in risk factor. All things considered I am not currently overly fearful that JP Morgan and Vanguard may singled out CU6 for anything other than risk control which if anything may in fact help to place a floor under the SP.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.08
Change
-0.120(5.45%)
Mkt cap ! $668.4M
Open High Low Value Volume
$2.21 $2.24 $2.01 $13.25M 6.372M

Buyers (Bids)

No. Vol. Price($)
1 10460 $2.07
 

Sellers (Offers)

Price($) Vol. No.
$2.08 73748 4
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.